Iimpawu eziqhelekileyo kunye ezinzulu kunye nokuthelekisa noDadewabo weDrug
I-Trileptal, igama eliqhelekileyo le-oxcarbazepine, liyeza ukuxhatshazwa ngamachiza ngamaxesha angasetyenziswa ekuphatheni i- bipolar disorder- nangona ukusebenza kwayo kusengacacanga.
Njengawo nawaphi na amayeza, kukho iziphumo ezinobungozi. Makhe sihlolisise le miphumo echaphazelekayo ukwenzela ukuba uzive ulungelele ukuba uqale lo myeza.
Ziziphi iimpembelelo eziqhelekileyo zokuThatheka?
Iziphumo eziqhelekileyo zeziphumo ziqhelekileyo kubonakala kubantu abathatha i-Trileptal.
Ngokutsho kwe-FDA, iimpembelelo eziqhelekileyo eziqhelekileyo ze-Trileptal ziquka:
- ukungcola
- kulala
- umbono obini okanye ezinye iingxaki ngombono
- uzive ukhathele
- isicaphulelo kunye / okanye ukuhlanza
- ataxia
- intlungu yesisu
- ukuthuthumela
- ukukhawuleza
- izifo - ngakumbi kubantwana
Ngokufanayo, kwisifundo sokuhlaziywa ngo-2011 kwisiCwangciso seCochrane seSichenical Review kwi-Trileptal (i-oxcarbazepine) kubantu abaneentsholongwane ezibangelwa yi-bipolar, iimpembelelo eziqhelekileyo zivakaliswe ukuba yi-dizziness, sedations, kunye nombono ongezantsi.
Ziziphi iimpembelelo eziphambili zeTrileptal?
Omnye umphumo osisigxina we-Trileptal kukuba kungenza ukuba i-sodium egazini lakho ibe phantsi, imeko ebizwa ngokuthi hyponatremia. Ngokutsho kwe-FDA, iimpawu ze-hyponatremia ziquka i-nausea, amandla aphantsi, intloko, ukudideka, okanye ukuxhamla. Kubonakala ngathi abantu basengozini yokuphuhlisa i-sodium ephantsi kwigazi kwiiveki ezi-12 zokuqala zokuthatha i-Trileptal.
Omnye umphumo osisigxina osisigxina usabela ngayo.
Izibonakaliso zempembelelo ezinokuthi zingabandakanywa okanye zingabandakanyi ukukhawuleza, ukuvuvukala ubuso, amehlo, imilomo, ulwimi, okanye iingxaki zokuphefumla. Imiba enzima kwaye inokuba yingozi ingenzeka ngenxa yokuthatha i-Trileptal, njenge-Stevens-Johnson syndrome kunye ne-epidermal necrolysis enetyhefu.
I-Trileptal inokuchaphazela nesibindi kunye neeseli zegazi.
Izibonakaliso okanye iimpawu zale miphumo yimizila zingabandakanya ukuphuka kwesikhumba okanye amehlo, ukunyundela okanye ukuphuma, ukukhathala okanye ubunzima obunzima, ubuhlungu obukhulu besifo, okanye ukusulelwa rhoqo okanye izifo ezingahambi.
Ekugqibeleni, njengamanye amayeza anxamnye ne-anti-seizure, i-Trileptal ingakhokelela kwimibono okanye kwizenzo zokuzibulala, le mpahla yecala ayinqabile, ivela kwi-1 kubantu abayi-500, ngokwe-FDA. Oko kuthethwa, khangela uncedo lwezoxinzelelo lwezonyango okanye ubiza 911 ukuba ufumana olu phulo.
Ngaba i-Trileptal kunye neTegretol Ngaba ziphumo ezifanayo?
I-Trileptal (i-oxcarbazepine) i-analog eya kwiTegretol (carbamazepine), oku kuthetha ukuba babelana nesakhiwo samachiza esifanayo. Zomibini ziyamachiza olwachasayo kunye neTegretol (carbamazepine) isetyenziswa ngamanye amaxesha ukuphatha ingxaki ye-bipolar. Nangona banesiprofayili esifanayo esifanelekileyo, kukho ukungafani okufihlakeleyo, ngokubhekiselele kwisifundo se-2011 sokuhlaziywa kwiDatabase yeCchrane yeSigqibo seSikweni .
Ngokomzekelo, ukugqithisa akuqhelekanga kwi-oxcarbazepine kune-carbamazepine. Sekunjalo, malunga nesithathu sabantu abaphikisayo kwi-carbamazepine nabo baxhamla kwi-oxcarbazepine. Ngoko nceda uxelele ugqirha ukuba unesisombululo sokuya ngaphambi kweTegretol (carbamazepine)
Kwakhona, i-hyponatremia inokuba yinto eqhelekileyo kubantu abathatha i-oxcarbazepine kunye ne-carbamazepine, ingakumbi ukuba loo mntu sele ekhulile kwaye enezinga le-sodium yezantsi.
Ndingenza ntoni?
Okokuqala kunye nangoko, ungalokothi uqale okanye unqande imithi ngaphandle kokubona kuqala ugqirha wakho. Kwakhona qiniseka ukuba ulandele ugqirha wakho xa ushicilelwe unyango.
Kwakhona kubalulekile ukwazi ukuba ezinye iziphumo ezichazwe ngasentla zingenzeka kwabanye abantu. Oku kungenjongo yokuba luhlu olubandakanya bonke okanye ukutshintsha ulwazi olunikezwa ngugqirha wakho. Ukuba uqaphela nayiphi na imiphumo emibi okanye unokukhathazeka xa uthatha i-Trileptal, nceda ukhangele kunye nogqirha wakho.
Imithombo:
Ukutya kunye noLawulo lweeMithi. (2011). Isikhokelo seMithi: Trileptal (oxcarbazepine) .
Vasudev et al. I-Oxcarbazepine yeziqulatho ezibonakalayo ezinobungozi bipolarlar. Cochrane Database Syst Rev. NgoDisemba ka-2011; (12): CD004857.